Clinical considerations and challenges in TAV-in-TAV procedures
Transcatheter aortic valve replacement (TAVR) has emerged as a viable treatment for aortic valve disease, including low-risk patients. However, as TAVR usage increases, concerns about long-term durability and the potential for addition interventions have arisen. Transcatheter aortic valve (TAV)-in-T...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-02-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2024.1334871/full |
| _version_ | 1797303339232264192 |
|---|---|
| author | Ahmad Hayek Ahmad Hayek Cyril Prieur Nicolas Dürrleman Quentin Chatelain Reda Ibrahim Anita Asgar Thomas Modine Walid Ben Ali |
| author_facet | Ahmad Hayek Ahmad Hayek Cyril Prieur Nicolas Dürrleman Quentin Chatelain Reda Ibrahim Anita Asgar Thomas Modine Walid Ben Ali |
| author_sort | Ahmad Hayek |
| collection | DOAJ |
| description | Transcatheter aortic valve replacement (TAVR) has emerged as a viable treatment for aortic valve disease, including low-risk patients. However, as TAVR usage increases, concerns about long-term durability and the potential for addition interventions have arisen. Transcatheter aortic valve (TAV)-in-TAV procedures have shown promise in selected patients in numerous registries, offering a less morbid alternative to TAVR explantation. In this review, the authors aimed to comprehensively review the experience surrounding TAV-in-TAV, summarize available data, discuss pre-procedural planning, highlight associated challenges, emphasize the importance of coronary obstruction assessment and provide insights into the future of this technique. |
| first_indexed | 2024-03-07T23:51:22Z |
| format | Article |
| id | doaj.art-b11225c4b44b47a59d75ddd5b4d50e03 |
| institution | Directory Open Access Journal |
| issn | 2297-055X |
| language | English |
| last_indexed | 2024-03-07T23:51:22Z |
| publishDate | 2024-02-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Cardiovascular Medicine |
| spelling | doaj.art-b11225c4b44b47a59d75ddd5b4d50e032024-02-19T04:54:34ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2024-02-011110.3389/fcvm.2024.13348711334871Clinical considerations and challenges in TAV-in-TAV proceduresAhmad Hayek0Ahmad Hayek1Cyril Prieur2Nicolas Dürrleman3Quentin Chatelain4Reda Ibrahim5Anita Asgar6Thomas Modine7Walid Ben Ali8Structural Heart Intervention Program, Montreal Heart Institute, Montreal, QC, CanadaDepartment of Interventional Cardiology, Hospices Civils de Lyon, Lyon, FranceDepartment of Interventional Cardiology, Hospices Civils de Lyon, Lyon, FranceStructural Heart Intervention Program, Montreal Heart Institute, Montreal, QC, CanadaStructural Heart Intervention Program, Montreal Heart Institute, Montreal, QC, CanadaStructural Heart Intervention Program, Montreal Heart Institute, Montreal, QC, CanadaStructural Heart Intervention Program, Montreal Heart Institute, Montreal, QC, CanadaService Médico-Chirurgical: Valvulopathies-Chirurgie Cardiaque-Cardiologie Interventionelle Structurelle, Hôpital Cardiologique de Haut Lévèque, CHU Bordeaux, Bordeaux, FranceStructural Heart Intervention Program, Montreal Heart Institute, Montreal, QC, CanadaTranscatheter aortic valve replacement (TAVR) has emerged as a viable treatment for aortic valve disease, including low-risk patients. However, as TAVR usage increases, concerns about long-term durability and the potential for addition interventions have arisen. Transcatheter aortic valve (TAV)-in-TAV procedures have shown promise in selected patients in numerous registries, offering a less morbid alternative to TAVR explantation. In this review, the authors aimed to comprehensively review the experience surrounding TAV-in-TAV, summarize available data, discuss pre-procedural planning, highlight associated challenges, emphasize the importance of coronary obstruction assessment and provide insights into the future of this technique.https://www.frontiersin.org/articles/10.3389/fcvm.2024.1334871/fullcoronary obstructionstructural valve deteriorationTAV-in-TAVTAVRCT planning |
| spellingShingle | Ahmad Hayek Ahmad Hayek Cyril Prieur Nicolas Dürrleman Quentin Chatelain Reda Ibrahim Anita Asgar Thomas Modine Walid Ben Ali Clinical considerations and challenges in TAV-in-TAV procedures Frontiers in Cardiovascular Medicine coronary obstruction structural valve deterioration TAV-in-TAV TAVR CT planning |
| title | Clinical considerations and challenges in TAV-in-TAV procedures |
| title_full | Clinical considerations and challenges in TAV-in-TAV procedures |
| title_fullStr | Clinical considerations and challenges in TAV-in-TAV procedures |
| title_full_unstemmed | Clinical considerations and challenges in TAV-in-TAV procedures |
| title_short | Clinical considerations and challenges in TAV-in-TAV procedures |
| title_sort | clinical considerations and challenges in tav in tav procedures |
| topic | coronary obstruction structural valve deterioration TAV-in-TAV TAVR CT planning |
| url | https://www.frontiersin.org/articles/10.3389/fcvm.2024.1334871/full |
| work_keys_str_mv | AT ahmadhayek clinicalconsiderationsandchallengesintavintavprocedures AT ahmadhayek clinicalconsiderationsandchallengesintavintavprocedures AT cyrilprieur clinicalconsiderationsandchallengesintavintavprocedures AT nicolasdurrleman clinicalconsiderationsandchallengesintavintavprocedures AT quentinchatelain clinicalconsiderationsandchallengesintavintavprocedures AT redaibrahim clinicalconsiderationsandchallengesintavintavprocedures AT anitaasgar clinicalconsiderationsandchallengesintavintavprocedures AT thomasmodine clinicalconsiderationsandchallengesintavintavprocedures AT walidbenali clinicalconsiderationsandchallengesintavintavprocedures |